Meridian Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-111,164
Closed -$3.23M 68
2015
Q4
$3.23M Hold
111,164
2.07% 14
2015
Q3
$3.02M Sell
111,164
-2,826
-2% -$80K 1.98% 14
2015
Q2
$3.12M Sell
113,990
-8,780
-7% -$247K 1.89% 13
2015
Q1
$3.28M Hold
122,770
2.35% 13
2014
Q4
$2.6M Buy
122,770
+3,620
+3% +$80.9K 1.89% 21
2014
Q3
$2.84M Buy
119,150
+900
+0.8% +$20.7K 2.17% 14
2014
Q2
$2.73M Hold
118,250
2.04% 15
2014
Q1
$2.7M Hold
118,250
2.14% 12
2013
Q4
$2.19M Buy
118,250
+39,850
+51% +$694K 1.74% 24
2013
Q3
$1.33M Hold
78,400
1.14% 39
2013
Q2
$1.32M Buy
+78,400
New +$1.3M 1.16% 38

Other funds holding NVO

Meridian Management's NVO Position: Q1 2016 in Review

Meridian Management sold out of Novo Nordisk (NVO) in Q1 2016, closing a stake of 111,164 shares — an estimated $3.23M sold.

Meridian Management first reported a position in NVO in Q2 2013 and held it in 11 quarters. The position peaked at $3.28M in Q1 2015. 535 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

  • Meridian Management reported no remaining Novo Nordisk position as of Q1 2016 after selling out during the quarter.
  • Meridian Management sold 111,164 Novo Nordisk shares in Q1 2016, an estimated $3.23M.
  • Meridian Management first reported a position in Novo Nordisk in Q2 2013 and held it in 11 quarters.
  • Meridian Management's Novo Nordisk position peaked at $3.28M in Q1 2015.
  • 535 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on Meridian Management's 13F filing for Q1 2016, filed 4 May 2016.